AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 161 min read$LIFE

Colis Peter George sold $4.6M of LIFE

Colis Peter George (CEO and Secretary) sold 120,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.39 ($37.64–$39.58, $4.61M total) across 7 trades over 2026-10-14 to 2026-10-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Colis Peter George
Published Oct 16, 2026, 9:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The disclosed sale may prompt short‑term price weakness, but long‑term impact depends on company performance.

02

Market read

A modest insider sell in a micro‑cap; limited trading relevance beyond immediate price reaction.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 4/10Timing: same-day filing

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

CEO sold 120,000 shares for $4.6M via a 10b5‑1 plan, reducing his stake to 1.54M shares.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

A $4.6M sale by the CEO is material for a micro‑cap and often triggers short‑term selling.

Market effects

Sector

Minimal impact on the broader technology sector.

Regional

Limited to U.S. markets where the stock trades.

Global

Low global relevance.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to fundamentals.

Key entities

  • Company
    Ethos Technologies Inc.

    Issuer of the stock (ticker LIFE) whose CEO executed the sale.

  • Person
    Colis Peter George

    CEO and Secretary of Ethos Technologies, reporting the insider transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

LIFE insider trading history →

Related articles

OCT 1
$LIFEMed

JPMorgan downgrades Ethos Technologies stock rating to neutral

JPMorgan downgraded Ethos Technologies (LIFE) to Neutral from Overweight, setting a $37 price target. The stock has surged 99% year-to-date. JPMorgan notes growth potential but cites balanced risk-reward and relative valuation concerns. Ethos reported Q2 2026 revenue of $189.6M, up 113% YoY, and raised full-year guidance to $727M-$731M. Other firms adjusted targets post-results.

investing.com2 min
SEP 3
$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

insidermonkey.com3 min
AUG 11
$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

fool.com7 min
AUG 5
$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

investing.com4 min